Beautyskin뷰티스킨

Beautyskin remains loss-making with shrinking revenue, though its share price has rebounded over three months from a sharp one-year decline.

Beautyskin, a Korean cosmetics maker spanning contract manufacturing, its own brands and distribution, reported trailing twelve-month revenue of ₩51.7B to H1 2026 with an operating loss of ₩1.7B and a net loss of ₩2.9B. Revenue fell 32.1% in 2025, and the company carries borrowings of ₩37.4B against cash of ₩4.1B. The shares closed at ₩2,145 on 2026-10-21, up 19.4% over three months but down 21.6% over one year.

What stands out

• Revenue has declined from ₩80.9B in 2024 to ₩54.9B in 2025, and trailing revenue to H1 2026 is ₩51.7B.
• The company has posted operating losses in each year shown from 2023 to H1 2026, and free cash flow is negative at about ₩-2.5B on a trailing basis.
• Liabilities are 209.3% of equity and borrowings are large relative to cash, so balance sheet leverage is a notable feature in the data.
• Recent filings include two major sales or supply contracts in September and October 2026, plus amended and added half-year report filings, but the data does not describe their contract values.
• Price-to-book is 1.1 and price-to-sales is 0.6, while P/E is not available because earnings are negative; the dividend yield is 0%.

What to watch

• The full half-year 2026 report and its amendment, to see whether losses narrow and how debt is handled.
• Further filings on the conversion price adjustment for the 7th round and any new holding disclosures, which may signal dilution or ownership changes.
• Whether the recently disclosed supply contracts translate into revenue growth; the data includes no news headlines to add context.